HINGHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) — Further expanding its global IP portfolio, Microbot Medical Inc. (Nasdaq CM: MBOT) received an official communication from the European Patent Office regarding its intention to grant European Patent Application No. 13 746 […]
Tag: ViRob
Microbot Medical Increases its Global IP Portfolio with Notice of Allowance from the European Patent Office
HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) — Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent Office that it will grant a patent for Application No. 08738207, which covers the Company’s ViRob™ technology platform. Including this […]
Microbot Medical Strengthens Global IP with Issued Patent in India Covering the Company’s ViRob™ Technology Platform
HINGHAM, Mass., June 25, 2018 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that Intellectual Property India has granted patent No. 296369, covering […]
Microbot Medical Inc. Announces European Patent Office’s Intent to Grant Patent for Device for the Prevention of Shunt Stenosis
HINGHAM, Mass., June 18, 2018 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that the European Patent Office (EPO) has notified the Company […]